Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy

View source ↗

Summary

Long-term follow-up data from patients who received the hLB-001 gene therapy for Methylmalonic Acidemia is being collected, with the study currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • hLB-001

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Methylmalonic Acidemia | Status: ACTIVE_NOT_RECRUITING